Allarity Therapeutics, Inc.

ALLR

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001860657

SEC filings (opens in a new tab)

No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Allarity Therapeutics, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of ALLR: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Q2 2022	Change
Holders	10	10	0
Shares	339.8K	230.9K	−108.9K (−32.1%)
Value	$694.0K	$304.0K	−$390.0K (−56.2%)

New holders (1)

Institutions that held Allarity Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to ALLR in Q2 2022
Institution	Shares	Value	% of portfolio
State Street Corp	12,974	$17.0K	0.00%

Sold out (1)

Institutions that held Allarity Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of ALLR in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Millennium Management LLC	94,082	$192.0K